Lobbying client · LD-2 disclosures
Kardiogenics, Inc.
California
12 filings from 1 registrant · 2023–2026 · latest filed Jul 24, 2026
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Defense
DEF
11 filings
Health Issues
HCR
11 filings
Medical/Disease Research/Clinical Labs
MED
11 filings
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 4016 119th CongressDepartment of Defense Appropriations Act, 20263 filingsthrough 2025
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Who did the lobbying
Every lobbyist named on this client's filings.
- Jenny Caroline Deberry Tenagrity Solutions, LLCCovered position: Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission12 filingsthrough 2026
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: kardiogenics-inc.